Proposed FDA rule would help drugmakers defend against lawsuits

The FDA plans to issue a new rule declaring drug labels approved by the agency pre-empt state regulations, a development that could help drug firms defend against liability lawsuits. The policy is expected to be issued as part of a larger drug-labeling rule intended to make drug information more accessible by using a new format.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care